Published in Am J Pathol on December 01, 1991
Biology and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci (2001) 1.89
Hairy leukoplakia: an unusual combination of transforming and permissive Epstein-Barr virus infections. J Virol (2000) 1.27
Epstein-Barr virus (EBV) in infectious mononucleosis: detection of the virus in tonsillar B lymphocytes but not in desquamated oropharyngeal epithelial cells. Mol Pathol (2000) 1.19
Epstein-Barr virus intrastrain recombination in oral hairy leukoplakia. J Virol (1994) 1.13
Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms. J Virol (2003) 1.13
Contribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cells. J Virol (2006) 1.06
The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression. J Virol (1994) 1.00
Epstein-Barr virus infection of Langerhans cell precursors as a mechanism of oral epithelial entry, persistence, and reactivation. J Virol (2007) 0.98
Activation of Kaposi's sarcoma-associated herpesvirus lytic gene expression during epithelial differentiation. J Virol (2005) 0.97
Epstein-Barr virus and the lacrimal gland pathology of Sjögren's syndrome. Am J Pathol (1993) 0.95
Epstein-Barr virus in the pathogenesis of oral cancers. Oral Dis (2017) 0.75
Detection of viral genomes in cultured cells and paraffin-embedded tissue sections using biotin-labeled hybridization probes. Virology (1983) 7.54
The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Annu Rev Immunol (1987) 6.94
Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med (1989) 6.66
Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens. J Immunol (1979) 5.06
Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N Engl J Med (1985) 4.78
Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells. J Virol (1985) 4.76
Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med (1984) 4.47
Monoclonal antibody to cytokeratin for use in routine histopathology. J Clin Pathol (1984) 4.36
Replication of Epstein-Barr virus in human epithelial cells infected in vitro. Nature (1984) 2.81
Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. J Virol (1990) 2.58
Expression of the Epstein-Barr virus nuclear protein 2 in rodent cells. J Virol (1986) 2.28
Production and characterization of monoclonal antibodies recognizing the alpha-chain subunits of human ia alloantigens. Immunology (1983) 1.85
Persistence of Epstein-Barr virus in the parotid gland. J Virol (1984) 1.75
Human epithelial cell expression of an Epstein-Barr virus receptor. J Gen Virol (1987) 1.73
Replication of EBV in epithelial cells during infectious mononucleosis. Nature (1977) 1.61
Use of keratin antibodies in tumor diagnosis. Semin Cancer Biol (1990) 1.58
EB virus induction is associated with B-cell maturation. Immunology (1986) 1.45
Measurement of the rate of epidermal terminal differentiation: expression of involucrin by S-phase keratinocytes in culture and in psoriatic plaques. J Invest Dermatol (1987) 1.42
Potential applications of anti-keratin antibodies in oral diagnosis. J Oral Pathol (1987) 1.33
Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2. J Virol (1989) 1.02
In situ hybridization to detect Epstein-Barr virus DNA in oral tissues of HIV-infected patients. Virchows Arch A Pathol Anat Histopathol (1987) 0.99
Oropharyngeal excretion of Epstein-Barr virus by patients with lymphoproliferative disorders and by recipients of renal homografts. Ann Intern Med (1978) 0.97
Oral hairy leukoplakia is not a specific sign of HIV-infection but related to immunosuppression in general. J Oral Pathol Med (1989) 0.95
Oral hairy leukoplakia in an HIV-negative renal transplant recipient. J Oral Pathol Med (1989) 0.93
Detection of EBV and HPV DNA sequences in oral "hairy" leukoplakia by in situ hybridization. J Med Virol (1988) 0.92
Immunological and histochemical analysis of regional variations of epidermal Langerhans cells in normal human skin. Histochem J (1984) 0.92
Absence of Langerhans cells in oral hairy leukoplakia, an AIDS-associated lesion. J Invest Dermatol (1987) 0.91
Detection of human papillomavirus and Epstein-Barr virus DNA sequences in oral mucosa of HIV-infected patients by the polymerase chain reaction. Am J Pathol (1990) 0.88
Oral hairy leukoplakia: observations in 95 cases and review of the literature. J Oral Pathol Med (1989) 0.86
Episodic hypothermia. Lancet (1973) 0.86
Development of an anticomplement immunoenzyme test for detection of EB virus nuclear antigen (EBNA) and antibody to EBNA. J Immunol Methods (1981) 0.83
Hairy leukoplakia: Epstein-Barr virus receptors on oral keratinocyte plasma membranes. Oral Surg Oral Med Oral Pathol (1989) 0.83
Detection of human papilloma viruses in paraffin wax sections with biotinylated synthetic oligonucleotide probes and immunogold staining. J Clin Pathol (1989) 0.81
Ultrastructural and immunohistochemical findings in oral hairy leukoplakia. Virchows Arch A Pathol Anat Histopathol (1988) 0.80
EBV and HSV infections in a patient who had undergone bone marrow transplantation: oral manifestations and diagnosis by in situ nucleic acid hybridization. Oral Surg Oral Med Oral Pathol (1989) 0.78
Epstein-Barr virus infection of epithelial cells derived from primary cultures of adenoidal tissue. Eur Arch Otorhinolaryngol (1990) 0.77
Intranuclear inclusions correlate with the ultrastructural detection of herpes-type virions in oral hairy leukoplakia. Am J Surg Pathol (1989) 0.77
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (1985) 30.47
A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell (1995) 3.17
Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet (1981) 2.36
Host genetic factors influence disease progression in chronic hepatitis C. Hepatology (2000) 2.26
Measurement of the movement of the S4 segment during the activation of a voltage-gated potassium channel. Pflugers Arch (1997) 2.22
Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol (2004) 2.16
Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation (1990) 2.13
Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am J Pathol (1999) 2.12
Epstein-Barr virus latent gene expression during the initiation of B cell immortalization. J Gen Virol (1989) 2.10
Current classifications of HIV-associated periodontal diseases. Br Dent J (1993) 2.03
Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med (1998) 2.03
Oral medicine--update for the dental practitioner oral cancer. Br Dent J (2006) 2.00
Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis. Lancet (2001) 1.89
Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells. Transplantation (2001) 1.78
Epstein-Barr virus coinfection and recombination in non-human immunodeficiency virus-associated oral hairy leukoplakia. J Infect Dis (1995) 1.75
Biological and biochemical observations on isolates of EB virus from the malignant epithelial cells of two nasopharyngeal carcinomas. Int J Cancer (1979) 1.62
Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft. Lancet (1980) 1.60
Recurrent aphthae: treatment with vitamin B12, folic acid, and iron. Br Med J (1975) 1.56
Sequence of a human immunoglobulin gamma 3 heavy chain constant region gene: comparison with the other human C gamma genes. Nucleic Acids Res (1986) 1.45
Increased numbers of cells with suppressor T cell phenotype in the peripheral blood of patients with infectious mononucleosis. Clin Exp Immunol (1981) 1.45
Increased hepatic iron and cirrhosis: no evidence for an adverse effect on patient outcome following liver transplantation. Hepatology (2000) 1.45
EB virus induction is associated with B-cell maturation. Immunology (1986) 1.45
Oral Medicine--update for the dental practitioner: oral white patches. Br Dent J (2005) 1.43
Hairy leukoplakia--a histological study. Histopathology (1991) 1.41
Oral medicine--update for the dental practitioner orofacial pain. Br Dent J (2006) 1.41
Oral medicine--update for the dental practitioner: red and pigmented lesions. Br Dent J (2005) 1.39
Recent non-sterile inoculation injuries to dental professionals in the Lothian region of Scotland. Br Dent J (1994) 1.39
An international survey in postgraduate training in Oral Medicine. Oral Dis (2011) 1.39
Multifocal hairy leukoplakia associated with Kaposi's sarcoma. Br Dent J (1992) 1.38
Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatry (1998) 1.37
Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial. Br Med J (Clin Res Ed) (1983) 1.37
Observations on the type of infection by Epstein-Barr virus in peripheral lymphoid cells of patients with infectious mononucleosis. Int J Cancer (1974) 1.37
Epstein-Barr virus-associated lymphoproliferative disorders in immunocompromised individuals. Adv Cancer Res (1991) 1.36
Distribution of transferrin saturation in an Australian population: relevance to the early diagnosis of hemochromatosis. Gastroenterology (1998) 1.35
Circulating Epstein-Barr virus-carrying B cells in acute malaria. Lancet (1991) 1.35
Functional and molecular aspects of voltage-gated K+ channel beta subunits. Ann N Y Acad Sci (1999) 1.34
Preparation and characterisation of homogeneous neurotoxin type A from Clostridium botulinum. Its inhibitory action on neuronal release of acetylcholine in the absence and presence of beta-bungarotoxin. Eur J Biochem (1982) 1.34
Prolonged exposure to acetylcholine: noise analysis and channel inactivation in cat tenuissimus muscle. J Physiol (1981) 1.33
DNA damage in human B cells can induce apoptosis, proceeding from G1/S when p53 is transactivation competent and G2/M when it is transactivation defective. EMBO J (1995) 1.33
Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse. J Physiol (1983) 1.33
Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells. J Gen Virol (1993) 1.33
Characterization of somatostatin receptors on human neuroblastoma tumors. Cell Growth Differ (1994) 1.30
Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study. J Clin Pathol (2005) 1.29
Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia. Am J Pathol (1998) 1.28
Molecular characterization of the Epstein-Barr virus DNA in three new Burkitt's lymphoma-derived cell lines. Mol Biol Med (1984) 1.27
Role of epithelium in EBV persistence and pathogenesis of B-cell tumours. Lancet (1988) 1.25
Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53. EMBO J (1995) 1.23
Serological studies in a student population prone to infection with human papilloma virus. J Hyg (Lond) (1972) 1.19
Prediction and demonstration of a novel Epstein-Barr virus nuclear antigen. Nucleic Acids Res (1988) 1.18
Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3. J Gastroenterol Hepatol (2001) 1.17
Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy. J Hepatol (1997) 1.16
B lymphocytes in the normal brain: contrasts with HIV-associated lymphoid infiltrates and lymphomas. Brain (2003) 1.16
X-Linked agammaglobulinemia patients are not infected with Epstein-Barr virus: implications for the biology of the virus. J Virol (1999) 1.15
Toxoplasmosis: effectiveness of enzyme immunoassay screening. Med Lab Sci (1989) 1.14
Detection of male DNA in the liver of female patients with primary biliary cirrhosis. J Hepatol (2000) 1.13
Non-secretion of blood group antigens and susceptibility to infection by Candida species. FEMS Microbiol Immunol (1989) 1.13
Risk of lymphoid neoplasia after cardiothoracic transplantation. a cohort study of the relation to Epstein-Barr virus. Transplantation (2000) 1.12
A mutation in the mucosal keratin K4 is associated with oral white sponge nevus. Nat Genet (1995) 1.12
Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A. Lancet (1981) 1.11
HPV type-specific prevalence using a urine assay in unvaccinated male and female 11- to 18-year olds in Scotland. Br J Cancer (2011) 1.11
Infection with E.B. virus and rheumatoid arthritis. Lancet (1979) 1.10
Lymphocytes activated by the Epstein-Barr virus to produce immunoglobulin do not express CD23 or become immortalized. Int J Cancer (1988) 1.10
Evidence that "myofibroblast-like" cells are the cellular source of capsular collagen in hepatocellular carcinoma. J Hepatol (1997) 1.09
Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients. J Immunol (1998) 1.09
Production of human monoclonal antibody to rhesus D antigen. Lancet (1983) 1.09
Rapid diagnosis of herpes simplex virus infections in conventional and shell vial cell cultures using monoclonal antibodies. J Virol Methods (1987) 1.08
Case report: lamivudine therapy for submassive hepatic necrosis due to reactivation of hepatitis B following chemotherapy. J Gastroenterol Hepatol (1999) 1.08
Denture stomatitis in the elderly. Oral Microbiol Immunol (1990) 1.08
The clinical entity of orofacial Crohn's disease. Q J Med (1991) 1.07
Coupling of voltage-dependent potassium channel inactivation and oxidoreductase active site of Kvbeta subunits. J Biol Chem (2001) 1.07
Detection of herpes viruses in clinical samples using real-time PCR. J Virol Methods (2001) 1.05
Post-NICE 2008: Antibiotic prophylaxis prior to dental procedures for patients with pulmonary arteriovenous malformations (PAVMs) and hereditary haemorrhagic telangiectasia. Br Dent J (2008) 1.05
The ins and outs of EBV infection. Trends Microbiol (2000) 1.05
Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B. Liver Transpl (2000) 1.04
Immunological heterogeneity and cellular mechanisms in myasthenia gravis. Ann N Y Acad Sci (1987) 1.04
Alteration of humoral responses to Candida in HIV infection. Br Dent J (1990) 1.04
Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution. Liver Transpl (2003) 1.03
Linkage disequilibrium analysis in Australian haemochromatosis patients indicates bipartite association with clinical expression. J Hepatol (1999) 1.03
The role of EBV in post-transplant malignancies: a review. J Clin Pathol (2000) 1.02
Effect of cysteine substitutions on the topology of the S4 segment of the Shaker potassium channel: implications for molecular models of gating. J Physiol (1999) 1.02
Blood group, secretor status and oral carriage of yeasts among patients with diabetes mellitus. Diabetes Res (1989) 1.00
Comparative trial of fluconazole and amphotericin in the treatment of denture stomatitis. Oral Surg Oral Med Oral Pathol (1993) 1.00
Molecular identification and characterisation of the human eag2 potassium channel. FEBS Lett (2002) 1.00
Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines. Br J Cancer (2010) 1.00
Profuse gastrointestinal haemorrhage due to delayed primary Epstein-Barr virus infection in an immunocompetent adult. Histopathology (2005) 1.00
Detection of Helicobacter pylori DNA in recurrent aphthous stomatitis tissue by PCR. J Oral Pathol Med (2000) 0.99
Epstein-Barr (EB) virus infection in homosexual men in London. Br J Vener Dis (1984) 0.98
Lambert-Eaton myasthenic syndrome: electrophysiological evidence for a humoral factor. Muscle Nerve (1982) 0.98
Elevated serum type IV collagen: a sensitive indicator of the presence of cirrhosis in haemochromatosis. J Hepatol (1999) 0.97
In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source. J Infect Dis (2000) 0.97
A prospective study in heart and lung transplant recipients correlating persistent Epstein-Barr virus infection with clinical events. Transplantation (1997) 0.97
Use of site-directed antibodies to probe the topography of the alpha 2 subunit of voltage-gated Ca2+ channels. FEBS Lett (1995) 0.97